MSB 2.23% $1.10 mesoblast limited

AstraZeneca Halts Vaccine Trial Due to Adverse Reaction

  1. 15,434 Posts.
    lightbulb Created with Sketch. 5527
    I decided it needed a new thread ... hehe


    Queensland Uni still in the hunt amongst others  .... and of course our very own Remestemcel-L ... a big set back sadly as I believe they were ahead in the game

    https://www.statnews.com/2020/09/08...d-adverse-reaction-in-participant-in-the-u-k/

    A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.

    A spokesperson for AstraZeneca, a front-runner in the race for a Covid-19 vaccine, said in a statement that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”

    It was not immediately clear who placed the hold on the trial, though it is possible it was placed voluntarily by AstraZeneca and not ordered by any regulatory agency. The nature of the adverse reaction and when it happened were also not immediately known, though the participant is expected to recover, according to an individual familiar with the matter
    Last edited by col69: 09/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.